|
|
|
Insider
Information: |
Duggan Robert W |
Relationship: |
Chief Executive Office... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
594,894,754 |
|
Indirect Shares
|
1,046,059 |
|
|
Direct
Value |
$5,224,874,671 |
|
|
Indirect Value
|
$9,749,033 |
|
|
Total
Shares |
595,940,813 |
|
|
Total
Value |
$5,234,623,704 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
0
|
Stock
price went up :
|
17
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
Percentage
Gain/Loss : |
31.8%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-07-13 |
4 |
B |
$3.55 |
$67,812 |
D/D |
18,919 |
2,278,526 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-08-31 |
4 |
B |
$4.18 |
$216,001 |
D/D |
50,000 |
2,328,526 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-01 |
4 |
B |
$4.31 |
$90,006 |
D/D |
20,100 |
2,348,626 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-03-18 |
4 |
B |
$23.01 |
$2,427,127 |
D/D |
105,486 |
2,378,486 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-05 |
4 |
B |
$4.43 |
$163,713 |
D/D |
36,696 |
2,385,322 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-06 |
4 |
B |
$4.47 |
$18,166 |
D/D |
3,999 |
2,389,321 |
2.37 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-07 |
4 |
B |
$4.50 |
$86,774 |
D/D |
19,036 |
2,408,357 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-08 |
4 |
B |
$4.80 |
$19,738 |
D/D |
4,112 |
2,412,469 |
2.37 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-18 |
4 |
B |
$4.75 |
$84,275 |
D/D |
17,742 |
2,430,211 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-19 |
4 |
B |
$4.75 |
$91,540 |
D/D |
19,216 |
2,449,427 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-06 |
4 |
B |
$18.54 |
$1,263,921 |
D/D |
65,400 |
2,452,886 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-09-20 |
4 |
B |
$4.88 |
$115,208 |
D/D |
23,529 |
2,472,956 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-07 |
4 |
B |
$19.59 |
$1,843,795 |
D/D |
94,100 |
2,546,986 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-10 |
4 |
B |
$20.38 |
$674,531 |
D/D |
31,964 |
2,578,950 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-17 |
4 |
B |
$23.15 |
$2,661,945 |
D/D |
107,300 |
2,686,250 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-18 |
4 |
B |
$25.06 |
$1,576,025 |
D/D |
61,819 |
2,748,069 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-11-08 |
4 |
B |
$4.75 |
$1,854,000 |
D/D |
390,000 |
2,862,956 |
2.45 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2006-12-29 |
4 |
B |
$4.85 |
$155,560 |
D/D |
31,661 |
2,894,617 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-19 |
4 |
B |
$22.24 |
$3,567,743 |
D/D |
150,123 |
2,898,192 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-25 |
4 |
B |
$24.94 |
$628,113 |
D/D |
25,187 |
2,923,379 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-26 |
4 |
B |
$24.47 |
$244,690 |
D/D |
10,000 |
2,933,379 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-27 |
4 |
B |
$22.95 |
$4,590 |
D/D |
200 |
2,933,579 |
2.37 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-04-28 |
4 |
B |
$23.85 |
$596,250 |
D/D |
25,000 |
2,958,579 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-05-01 |
4 |
B |
$23.81 |
$460,715 |
D/D |
19,348 |
2,977,927 |
2.45 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
10% Owner |
|
2017-05-02 |
4 |
B |
$23.40 |
$117,000 |
D/D |
5,000 |
2,982,927 |
2.45 |
- |
|
318 Records found
|
|
Page 8 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|